News

How Ryght AI's Webinar Innovates Clinical Trial Selection

How Ryght AI's Webinar Innovates Clinical Trial Selection

Transforming Clinical Trials with AI Technology

In the dynamic field of healthcare, clinical trials are pivotal for advancing medical knowledge and patient treatments. However, traditional methods of site selection often hinder progress. Ryght AI aims to change this landscape through an innovative approach that leverages cutting-edge technology to streamline processes. This company specializes in AI-powered solutions that optimize clinical trial site selection and feasibility, ensuring quicker patient enrollment and more effective research outcomes.

Free Webinar Highlighting the AI-Powered Platform

Ryght AI is excited to announce a complimentary webinar titled "From Protocol to Perfect Match: See AI-Powered Site Selection in Action." This engaging 30-minute session will showcase how the company’s AI Site Twin technology radically reduces site selection timelines. Attendees will witness a real-time demonstration illustrating the platform's capabilities.

Challenges in Clinical Trial Recruitment

Clinical trial sponsors and Contract Research Organizations (CROs) consistently grapple with the challenge of timely site selection. The use of outdated tools, such as spreadsheets and incomplete datasets, leads to prolonged start-up times, which can sabotage enrollment efforts. Reports indicate that around 80% of clinical trials encounter enrollment delays, resulting in financial setbacks and extending the time it takes for patients to receive new treatments.

Expert Insights from Ryght AI's CEO

Simon Arkell, the CEO and Co-Founder of Ryght AI, emphasizes the importance of leveraging AI technology for more efficient site selection. He noted, "Traditional methods are draining resources. Our AI Site Twin technology provides data-driven profiles of potential research sites worldwide. Attendees will see firsthand how rapid transitions from protocol uploads to site engagement can be achieved when employing our innovative solutions."

What You Can Expect from the Webinar

This live session promises valuable insights and demonstrations of the platform's key features:

Understanding AI Site Twin Technology

The webinar will begin with an exploration of Ryght's AI Site Twin network. This network comprises dynamic digital replicas of clinical research sites that are continuously updated with live data. Participants will learn how these versions encompass current operational capacities and historical performance metrics that inform better decision-making.

The Power of Real-Time Data Analysis

An essential part of the demonstration will focus on Ryght’s Network Navigator tool, which analyzes a clinical trial protocol in real time. This will illustrate how the tool identifies eligible sites worldwide based on previous performance and the specific needs of the current study, speeding up the selection process effectively.

Streamlined Feasibility with Automated Workflows

Another exciting aspect of the webinar will involve a look at Ryght’s Feasibility Accelerator. This feature utilizes AI to quickly create feasibility questionnaires utilizing information from the AI Site Twin, allowing sites to respond rapidly. The ability to track progress in real time is a significant advancement in simplifying study startup procedures.

Registration Information

To join "From Protocol to Perfect Match: See AI-Powered Site Selection in Action," interested parties can register for free online. The webinar will take place on December 17, 2025, from 12:00 PM to 12:30 PM EST. For those who cannot attend, there will be an on-demand recording available post-event.

Exclusive Opportunities for Participants

Individuals attending the live session will have a chance to access a complimentary trial of the Ryght platform. Eligible participants can submit a de-identified protocol and gain insights into the most suitable research sites and principal investigators ready to participate in studies.

About Ryght AI

Ryght AI is revolutionizing how clinical trials are conducted through its sophisticated platform, which harnesses the power of AI to create Site Twins. These cutting-edge data models provide insights into every clinical research site worldwide. By improving site selection and feasibility processes, Ryght AI significantly enhances the timeline for clinical trial studies, ensuring that vital research is conducted efficiently and effectively.

Frequently Asked Questions

What is the focus of Ryght AI's webinar?

The webinar focuses on demonstrating how AI technology improves site selection and feasibility in clinical trials.

How long is the webinar and when does it take place?

The webinar lasts for 30 minutes, occurring on December 17, 2025, from 12:00 PM to 12:30 PM EST.

What technology will be highlighted in the webinar?

Key technologies include Ryght's AI Site Twin and Network Navigator, which enhance the site selection process.

Is registration for the webinar free?

Yes, registration for the webinar is complimentary, and an on-demand recording will be available for those unable to attend.

What benefits do live participants receive?

Live attendees are eligible for a complimentary trial of the Ryght platform, including a comprehensive site analysis.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AIM-T1 Wins at CES 2027, Paving AI in Electronics

Updated Category News Views 41

AIM-T1: A Game-Changer for Electronics Manufacturing You ever wonder how a single gizmo could shake up the entire electronics manufacturing world? Well, A.I.Matics' AIM-T1 has done just that by snagging two coveted CES Innovation Awards for 2027. In the cutthroat arenas of Artificial Intelligence and Construction & Industrial Tech, this platform's getting the spotlight...

Continue Reading
LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

Updated Category News Views 130

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Continue Reading
Bright Start 529 Nails 8th Gold Rating: A Game Changer

Updated Category News Views 89

Gold Again: The Bright Start 529 Legacy Shining brightly for the eighth consecutive time, Illinois' Bright Start 529 College Savings Plan has snagged yet another Gold rating from Morningstar. That's no small feat folks, especially in a landscape where nine Gold ratings grace the entire roster of 529 plans in the country. Illinois' treasure chest plan under Treasurer...

Continue Reading
Greenberg Traurig Shareholders Earn Law360 MVP Honors

Updated Category News Views 52

A Spotlight on Legal Excellence In the tough-as-nails world of legal battles, a select few rise above the rest, but it's not every day you see three folks from the same shop getting the nod as MVPs. That's the story coming out of Greenberg Traurig, where shareholders Gregory A. Fishman, Michael J. Thomas, and David B. Weinstein made the cut for the 2026 Law360 MVP honors....

Continue Reading
Greenberg Traurig Secures Top Honors at LBA Awards

Updated Category News Views 158

A Celebration of Achievements in South Florida Nothing signifies success like a room full of applause and a shiny award, especially when it comes from a community as influential as South Florida's construction scene. This past October, Greenberg Traurig, a heavy hitter in the legal sphere, clinched its title as the Law Firm of the Year from the Latin Builders Association...

Continue Reading
RAI's TrustX Lab Unveils AI Assurance Framework

Updated Category News Views 52

Pushing the Envelope on AI Control Alright, AI wonks, the Responsible AI Institute just introduced a new sheriff in town. It's called the TrustX Assurance Lab, and it was rolled out during RAISE 2026. We're talking about an independent setup designed to answer whether autonomous AI can stay within its limits. Who's involved? A lot of brainpower from member organizations...

Continue Reading
Lindian Secures Key Offtake for Rare Earths Expansion

Updated Category News Views 54

Lindian Resources Drives New Deal in Rare Earths Ah, the sweet smell of another strategic move in the resources game. Lindian Resources Limited is strutting its stuff down under by securing a binding offtake for a hefty 30,000 tonnes of Monazite Concentrate. Now, that's a weighty lift in the world of rare earths, and it kicks off just in time for their December production...

Continue Reading
ResMed Faces Probe: Potential Breach Alert for Investors

Updated Category News Views 107

Cracks Surfacing at ResMed? Alright, folks, ResMed Inc. (NYSE: RMD) is facing a bit of heat these days. We're talking about a shareholder alert as Levi & Korsinsky, noted legal hounds when it comes to financial misconduct, have decided to dig deep into ResMed. They're looking to uncover any possible breaches of fiduciary duties by some of the top brass at this sleep apnea...

Continue Reading
Stellus Capital Delivers Solid Q3 Amid Turbulent Times

Updated Category News Views 106

Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...

Continue Reading
LG Wins CES Honor with Breakthrough Battery Diagnostic Tech

Updated Category News Views 204

Speeding Up Diagnostics: A Major Leap Forward In a world where every second counts, LG Energy Solution strikes gold with their latest innovation, Re.Pulse. CES Innovation Awards 2027 has honored LG for this slick piece of tech that trims down battery diagnosis time from a snail's pace seven hours to a lightning-fast 10 minutes. It's not just about speed—it’s also...

Continue Reading

Top 5 Most Recently Viewed Articles

Xsolla Unveils Xsolla ZK: A New Era for Web3 Gaming

Updated Category News Views 233

Xolla Takes a Bold Step into Web3 with Xsolla ZK In a groundbreaking move, Xsolla has announced its intention to launch Xsolla ZK, which aims to revolutionize the video game industry by harnessing the power of blockchain technology. This innovative platform will feature a digital backpack that allows game developers and item creators to store and manage in-game assets...

Continue Reading
Titan Machinery Strategically Exits German Dealership Market

Updated Category News Views 237

Titan Machinery's German Dealership Divestiture Plans Titan Machinery Inc. (Nasdaq: TITN), recognized as a prominent network of agricultural and construction equipment stores, has made a significant announcement regarding its dealership operations in Germany. This decision reflects the company’s strategy to optimize its global operations and maximize returns. The...

Continue Reading
Analyzing Ally Financial: A Comprehensive Stock Outlook

Updated Category News Views 207

Exploring Ally Financial's Landscape and Future Ally Financial Inc. (NYSE: ALLY) is a forward-thinking digital financial services firm that excels in automotive finance. As the company navigates a fluctuating market, it showcases a dynamic blend of opportunities and challenges. The eyes of investors and market analysts remain on Ally as it adapts and evolves through...

Continue Reading
Globe Life Receives Closure on DOJ Investigation, Focuses on Growth

Updated Category News Views 118

Globe Life Concludes DOJ Investigation and Looks Ahead Globe Life Inc. (NYSE: GL) has recently received news from the U.S. Attorney's Office for the Western District that its investigation into the company's practices has been officially closed. This positive development comes as Globe Life strives to maintain its reputation and growth in the life insurance sector....

Continue Reading
Recent Insider Sale at Gartner Inc Sparks Investor Interest

Updated Category News Views 111

Recent Insider Trading at Gartner Inc In a noteworthy development that has drawn the attention of investors, Claire Herkes, the Executive Vice President of Conferences at Gartner Inc (NYSE: IT), recently sold 478 shares of the company. This transaction took place at a significant price of $506.01 per share, resulting in a total sale value that exceeds $240,000. Insider...

Continue Reading